AI: FineHeart Strengthens Its Management Team in the Run up to the ICOMS FLOWMAKER First-In-Human Trials

ICOMS FLOWMAKER, First Fully Implantable Electro-Physiological Cardiac Assistance Device  

FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced appointment of two experienced medical device experts to support the company’s next clinical and industrial phases.

Latest Aithority Insights : NVIDIA Raises the Standard of Low Code DevOps with the NVIDIA AI Enterprise 2.1

“We are very proud to welcome two internationally renowned executives who have both played a major role in the development and manufacturing of breakthrough implantable devices. Each of them has been captivated by the technological and clinical progress that the ICOMS FLOWMAKER® represents. Their arrival gives us even more confidence as we head to the First-In-Human implantation our device, scheduled for 2023. I am also very pleased that Sophie Jonquière has joined us thereby enhancing the feminization of our management committee, in line with our parity objectives. Furthermore, their arrival reinforces our ability to expand our industrial production capacities as we grow.” declared Arnaud Mascarell, CEO & co-founder of FineHeart.

Guillaume Buc, Chief Technical Officer
Before joining FineHeart, Guillaume was Technical and R&D Director at Pixium Vision for more than 9 years. His expertise and passion were instrumental in the development of the PRIMA retinal implant, which is now in its commercialization phase. Prior to that, he held several strategic management positions at GE Healthcare in Europe for more than 25 years, before becoming Technical Director of the Interventional Cardiology Department. Guillaume holds an engineering degree from Ecole Polytechnique in applied mathematics, and from Ecole Nationale Supérieure des Télécommunications de Paris in image processing and computer science.

Read More About AI News : Role of AI in Helping B2B companies that are Missing Out on Buyer Intent Data

“Few projects in healthcare have as many innovative features as the ICOMS FLOWMAKER®. The scientific and technological breakthroughs achieved, based on the exceptional vision of FineHeart’s founders, are colossal and unprecedented in the field of cardiac assist pumps. I am honored to lead the technical team of this company that is redefining the future of cardiology.” said Guillaume Buc.

Sophie Jonquière, Chief Procurement & Supply Chain Officer
Sophie is a medical device manufacturing and supply chain specialist. For 15 years, she held various positions at Zimmer Biomet in the orthopedic implant activity, during the industrialization process, and then production management and distribution before heading up Manufacturing Operations for spinal implants and instruments for EMEA. She started her career as a Manufacturing Process Engineer at Hemodia. Sophie Jonquière is an engineer, Materials Science and Engineering from INSA Lyon, and a graduate of IAE Bordeaux, Business Management.

“I am delighted to bring my know-how in medical device manufacturing processes to this extremely exciting and ambitious project. The ICOMS FLOWMAKER® has everything it takes to change the lives of patients with severe heart failure, a disease impacting such a large number of people.” said Sophie Jonquière

Future of AI-driven Customer Relationship:  Microsoft’s Viva Sales and the Future of AI-driven Customer Relationship and Experience Management

[To share your insights with us, please write to sghosh@martechseries.com]